Results 121 to 130 of about 6,218 (156)

Nirmatrelvir+ritonavir

Reactions Weekly
  +5 more sources

Molnupiravir/nirmatrelvir+ritonavir

Reactions Weekly, 2023
  +4 more sources

Oral Antiviral Treatment for COVID-19: A Comprehensive Review on Nirmatrelvir/Ritonavir

Viruses, 2022
Karolina Akinosoglou, Georgios Schinas, Akinosoglou Karolina   +2 more
exaly  

Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry

EClinicalMedicine, 2023
Iker Falces-Romero, Francesco Marchesi, Livio Pagano   +2 more
exaly  

Dexamethasone/nirmatrelvir+ritonavir

Reactions Weekly, 2023
openaire   +1 more source

Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?

Biomedicine and Pharmacotherapy, 2023
Zatollah Asemi, Michael R Hamblin, Mohammad Yousef Memar   +2 more
exaly  

Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses

Antiviral Research, 2023
Qiuwei Pan, Pengfei Li, Marla Lavrijsen   +2 more
exaly  

Molnupiravir and Nirmatrelvir-Ritonavir: Oral Coronavirus Disease 2019 Antiviral Drugs

Clinical Infectious Diseases, 2023
Louis D Saravolatz, Sharma Mamta
exaly  

Global prevalence of SARS-CoV-2 3CL protease mutations associated with nirmatrelvir or ensitrelvir resistance

EBioMedicine, 2023
Kelvin To, Wan Mui Chan, Abdullah Syed Muhammad Umer   +2 more
exaly  

Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infection

Journal of Pharmaceutical Analysis, 2023
, Dongming Xing, Xiaolin Wu
exaly